Blood biomarkers in drug-resistant cancer tumour cells
While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumour resistance to two common hormone therapies. In a study, the Duke-led team reported that they isolated multiple key gene alterations in the circulating prostate tumour cells of patients who […]
